- Home
- PBYI vs EVC Comparison
PBYI vs EVC Comparison
Compare PBYI & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- EVC
- Stock Information
- Founded
- PBYI 2010
- EVC 1996
- Country
- PBYI United States
- EVC United States
- Employees
- PBYI N/A
- EVC N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- PBYI Health Care
- EVC Industrials
- Exchange
- PBYI Nasdaq
- EVC Nasdaq
- Market Cap
- PBYI 153.2M
- EVC 229.5M
- IPO Year
- PBYI N/A
- EVC 2000
- Fundamental
- Price
- PBYI $3.09
- EVC $2.42
- Analyst Decision
- PBYI Strong Buy
- EVC Hold
- Analyst Count
- PBYI 1
- EVC 1
- Target Price
- PBYI $7.00
- EVC $1.75
- AVG Volume (30 Days)
- PBYI 754.5K
- EVC 608.7K
- Earning Date
- PBYI 02-27-2025
- EVC 03-04-2025
- Dividend Yield
- PBYI N/A
- EVC 8.33%
- EPS Growth
- PBYI 492.79
- EVC N/A
- EPS
- PBYI 0.47
- EVC N/A
- Revenue
- PBYI $243,569,000.00
- EVC $1,146,066,000.00
- Revenue This Year
- PBYI N/A
- EVC N/A
- Revenue Next Year
- PBYI N/A
- EVC N/A
- P/E Ratio
- PBYI $6.63
- EVC N/A
- Revenue Growth
- PBYI 6.30
- EVC 122.49
- 52 Week Low
- PBYI $2.23
- EVC $1.33
- 52 Week High
- PBYI $7.73
- EVC $4.41
- Technical
- Relative Strength Index (RSI)
- PBYI 49.17
- EVC 49.96
- Support Level
- PBYI $2.92
- EVC $2.21
- Resistance Level
- PBYI $4.06
- EVC $2.70
- Average True Range (ATR)
- PBYI 0.29
- EVC 0.16
- MACD
- PBYI 0.01
- EVC 0.01
- Stochastic Oscillator
- PBYI 27.07
- EVC 41.84
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.